Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.
from Latest News https://ift.tt/3EsXDNW
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Friday, October 29, 2021
Related Posts:
Practo is looking to scale faster riding on Covid-19, says CEO Shashank NDAs telemedicine became the preferred medium for consultations, the fir… Read More
ITC continues to underperform but analysts say the stock is attractiveA tax overhang and ESG concerns over cigarettes have been among key fa… Read More
Covid-19 impact: E-commerce companies may see 50% rise in festive salesFlipkart, Amazon projected to cross $7 billion in these sales during C… Read More
Covid-19: Mass production of Sputnik V likely to take several monthsVaccine makers here feel the Sputnik is still a work in progress and n… Read More
0 comments: